Cite
HARVARD Citation
Moazedi-Fuerst, F. et al. (2015). Decrease in autoantibody titres during long-term treatment of scleroderma with rituximab: a promising surveillance marker of therapy?. Scandinavian journal of rheumatology. pp. 519-520. [Online].